1. Home
  2. SNY vs LOW Comparison

SNY vs LOW Comparison

Compare SNY & LOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • LOW
  • Stock Information
  • Founded
  • SNY 1994
  • LOW 1946
  • Country
  • SNY France
  • LOW United States
  • Employees
  • SNY N/A
  • LOW N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • LOW RETAIL: Building Materials
  • Sector
  • SNY Health Care
  • LOW Consumer Discretionary
  • Exchange
  • SNY Nasdaq
  • LOW Nasdaq
  • Market Cap
  • SNY 116.5B
  • LOW 122.5B
  • IPO Year
  • SNY N/A
  • LOW N/A
  • Fundamental
  • Price
  • SNY $48.70
  • LOW $227.54
  • Analyst Decision
  • SNY Buy
  • LOW Buy
  • Analyst Count
  • SNY 2
  • LOW 26
  • Target Price
  • SNY $62.50
  • LOW $273.73
  • AVG Volume (30 Days)
  • SNY 2.1M
  • LOW 2.6M
  • Earning Date
  • SNY 07-24-2025
  • LOW 08-19-2025
  • Dividend Yield
  • SNY 3.31%
  • LOW 2.10%
  • EPS Growth
  • SNY 39.56
  • LOW N/A
  • EPS
  • SNY 5.45
  • LOW 12.09
  • Revenue
  • SNY $48,817,552,946.00
  • LOW $83,240,000,000.00
  • Revenue This Year
  • SNY $3.39
  • LOW $1.77
  • Revenue Next Year
  • SNY $7.05
  • LOW $3.62
  • P/E Ratio
  • SNY $17.56
  • LOW $18.88
  • Revenue Growth
  • SNY N/A
  • LOW N/A
  • 52 Week Low
  • SNY $45.80
  • LOW $206.39
  • 52 Week High
  • SNY $60.12
  • LOW $287.01
  • Technical
  • Relative Strength Index (RSI)
  • SNY 43.32
  • LOW 58.53
  • Support Level
  • SNY $47.64
  • LOW $219.14
  • Resistance Level
  • SNY $49.37
  • LOW $232.17
  • Average True Range (ATR)
  • SNY 0.68
  • LOW 4.82
  • MACD
  • SNY 0.14
  • LOW 1.39
  • Stochastic Oscillator
  • SNY 30.56
  • LOW 82.33

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About LOW Lowe's Companies Inc.

Lowe's is the second-largest home improvement retailer in the world, operating 1,750 stores in the United States, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's primarily targets retail do-it-yourself (around 70% of sales) and do-it-for-me customers, but has expanded its commercial and professional business clients to 30% from less than 20% in the past six years. We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management's market size estimates.

Share on Social Networks: